ATE45284T1 - Wirkstoff-vorlaeufer enthaltende pharmazeutische zusammensetzungen, verfahren zu ihrer herstellung, verfahren zur herstellung von wirkstoff-vorlaeufer-verbindungen und die erhaltenen verbindungen. - Google Patents
Wirkstoff-vorlaeufer enthaltende pharmazeutische zusammensetzungen, verfahren zu ihrer herstellung, verfahren zur herstellung von wirkstoff-vorlaeufer-verbindungen und die erhaltenen verbindungen.Info
- Publication number
- ATE45284T1 ATE45284T1 AT86200748T AT86200748T ATE45284T1 AT E45284 T1 ATE45284 T1 AT E45284T1 AT 86200748 T AT86200748 T AT 86200748T AT 86200748 T AT86200748 T AT 86200748T AT E45284 T1 ATE45284 T1 AT E45284T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- prodrug
- compounds
- processes
- drugs
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title abstract 7
- 239000000651 prodrug Substances 0.000 title abstract 7
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 150000007524 organic acids Chemical class 0.000 abstract 2
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000008064 anhydrides Chemical class 0.000 abstract 1
- 235000019658 bitter taste Nutrition 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/54—Preparation of carboxylic acid anhydrides
- C07C51/567—Preparation of carboxylic acid anhydrides by reactions not involving carboxylic acid anhydride groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
- C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/02—Saturated compounds containing hydroxy or O-metal groups
- C07C62/06—Saturated compounds containing hydroxy or O-metal groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8501408 | 1985-05-15 | ||
| EP86200748A EP0202703B1 (de) | 1985-05-15 | 1986-05-01 | Wirkstoff-Vorläufer enthaltende pharmazeutische Zusammensetzungen, Verfahren zu ihrer Herstellung, Verfahren zur Herstellung von Wirkstoff-Vorläufer-Verbindungen und die erhaltenen Verbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE45284T1 true ATE45284T1 (de) | 1989-08-15 |
Family
ID=19845998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86200748T ATE45284T1 (de) | 1985-05-15 | 1986-05-01 | Wirkstoff-vorlaeufer enthaltende pharmazeutische zusammensetzungen, verfahren zu ihrer herstellung, verfahren zur herstellung von wirkstoff-vorlaeufer-verbindungen und die erhaltenen verbindungen. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4863965A (de) |
| EP (1) | EP0202703B1 (de) |
| JP (1) | JPS61263916A (de) |
| AT (1) | ATE45284T1 (de) |
| CA (1) | CA1266828A (de) |
| DE (1) | DE3664869D1 (de) |
| DK (1) | DK225986A (de) |
| FI (1) | FI861971A7 (de) |
| IL (1) | IL80787A (de) |
| NO (1) | NO861903L (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2072360A1 (en) * | 1989-12-26 | 1991-06-27 | Abraham J. Domb | Prodrug anhydride compositions |
| NZ240846A (en) * | 1990-12-06 | 1994-04-27 | Hoechst Ag | Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions |
| CA2108041A1 (en) * | 1991-03-29 | 1992-09-30 | Nicholas S. Bodor | Targeted drug delivery via mixed phosphate derivatives |
| US6120751A (en) | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
| US6090800A (en) * | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
| US20030060465A1 (en) * | 2000-12-19 | 2003-03-27 | Jilani Jamal A. | Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2577699A (en) * | 1949-09-10 | 1951-12-04 | Bristol Lab Inc | Penicillin anhydrides |
| US3763152A (en) * | 1968-09-16 | 1973-10-02 | American Home Prod | Neutral cephalosporin anhydrides |
| US4206220A (en) * | 1978-07-13 | 1980-06-03 | Interx Research Corporation | Prodrugs for the improved delivery of non-steroidal anti-inflammatory agents |
-
1986
- 1986-05-01 AT AT86200748T patent/ATE45284T1/de active
- 1986-05-01 EP EP86200748A patent/EP0202703B1/de not_active Expired
- 1986-05-01 DE DE8686200748T patent/DE3664869D1/de not_active Expired
- 1986-05-12 FI FI861971A patent/FI861971A7/fi not_active Application Discontinuation
- 1986-05-13 NO NO861903A patent/NO861903L/no unknown
- 1986-05-14 US US06/863,131 patent/US4863965A/en not_active Expired - Fee Related
- 1986-05-14 CA CA000509171A patent/CA1266828A/en not_active Expired - Fee Related
- 1986-05-15 DK DK225986A patent/DK225986A/da not_active Application Discontinuation
- 1986-05-15 JP JP61111784A patent/JPS61263916A/ja active Pending
- 1986-11-26 IL IL80787A patent/IL80787A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK225986A (da) | 1986-11-16 |
| NO861903L (no) | 1986-11-17 |
| IL80787A (en) | 1991-08-16 |
| DE3664869D1 (en) | 1989-09-14 |
| CA1266828A (en) | 1990-03-20 |
| EP0202703B1 (de) | 1989-08-09 |
| US4863965A (en) | 1989-09-05 |
| DK225986D0 (da) | 1986-05-15 |
| FI861971A7 (fi) | 1986-11-16 |
| JPS61263916A (ja) | 1986-11-21 |
| EP0202703A1 (de) | 1986-11-26 |
| FI861971A0 (fi) | 1986-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
| WO1999044581A3 (en) | Pharmaceutical composition of topiramate | |
| ATE103893T1 (de) | 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung; diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel. | |
| EP0629400B1 (de) | Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer | |
| IL97796A0 (en) | Pharmaceutical compositions containing n-alkylated 1,4-dihydropyridine-dicarboxylic acid esters,certain such compounds and their preparation | |
| HU201672B (en) | Process for producing pharmaceutical compositions comprising podophyllotoxin | |
| DE3664869D1 (en) | Pharmaceutical compositions of the prodrug type, a process for the preparation thereof, a process for the preparation of them as prodrug functioning compounds and compounds obtained therein | |
| ATE72447T1 (de) | Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung. | |
| US3959470A (en) | Psychotropic medicinal preparation | |
| ATE18050T1 (de) | Triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| DE50006842D1 (de) | 4-benzylaminochinoline konjugate mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung | |
| ES8308833A1 (es) | "un metodo para la preparacion de 3-fenil-1-indanaminas". | |
| EP0561597A1 (de) | Physostigmin-Derivate, ihre Verwendung und sie enthaltende pharmazeutische Formulierungen | |
| US4892876A (en) | Method for inhibiting HIV and an pharmaceutical composition therefor | |
| DE3821392A1 (de) | Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on (ebselen) | |
| ATE37370T1 (de) | Triazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| Modell | Drugs in Current Use 1958 | |
| ATE91890T1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
| DE3406837C2 (de) | ||
| ATE19777T1 (de) | Pyridobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| FR2547730A1 (fr) | Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie | |
| KR890009919A (ko) | 4- 헤테로아릴-1,3- 벤조디아제핀 및 2-치환된-α-(헤테로아릴) 벤젠에탄아민, 이의 제조방법 및 약제로서의 이의 용도 | |
| DE345883T1 (de) | Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin. | |
| KR910006270A (ko) | 약리적 활성 화합물 제법 및 용도 | |
| DE3372772D1 (en) | Quinazolinone derivatives, process for their preparation and their use in medicaments |